Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDIV × Sirolimus × Sarcoma × Clear all

Phase

Status

Sponsor Class

OTHER 23 NIH 12 NETWORK 1 INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

nilotinib 1 Sirolimus 1 Gemcitabine 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02429973 2015-04-29

GEIS-29

Broto, Javier Martín, M.D.

Phase 2 Completed

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡